Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells

This publication has 32 references indexed in Scilit:

• Pharmacological study of dihydroetorphine in cloned μ-, δ- and κ-opioid receptors
  European Journal of Pharmacology: Molecular Pharmacology, 1995
• Chronic opioid treatment of neuroblastoma X dorsal root ganglion neuron hybrid F11 cells results in elevated GM1 ganglioside and cyclic adenosine monophosphate levels and onset of naloxone‐evoked decreases in membrane K⁺ currents
  Journal of Neuroscience Research, 1995
• Physical Dependence Produced by Dihydroetorphine in Mice.
  Biological & Pharmaceutical Bulletin, 1994
• Antinociceptive Effect of Dihydroetorphine and Its Tolerance/Dependence Liability in Mice.
  Biological & Pharmaceutical Bulletin, 1993
• Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation
  Cell, 1991
• Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons
  Trends in Pharmacological Sciences, 1990
• β-Endorphin-(1–27) antagonizes β-endorphin- but not morphine-, D-PEN2-D-PEN2-enkephalin- and U50, 488H-induced analgesia in mice
  Neuropharmacology, 1988
• Opioid receptor types and membrane ion channels
  Trends in Neurosciences, 1986
• Unidirectional non-cross tolerance to etorphine in morphine-tolerant mice and role of the blood-brain barrier
  Toxicology and Applied Pharmacology, 1980
• Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine
  Journal of the American Chemical Society, 1967